Henry Schein Inc. Reaches New 12-Month High at $113.69 (HSIC)
Henry Schein (NASDAQ:HSIC) set a new 52-week high during trading hours on Wednesday, American Banking News.com reports. The company traded as high as $113.69 and last traded at $111.91, with a volume of 307,283 shares. The stock had previously closed at $112.98.
Several analysts have recently commented on the stock. Analysts at ISI Group raised their price target on shares of Henry Schein from $106.00 to $110.00 in a research note to investors on Monday, October 14th. They now have a “neutral” rating on the stock. Separately, analysts at Ned Davis Research downgraded shares of Henry Schein from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 30th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note to investors on Monday, September 16th. They now have a $110.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $96.14.
Henry Schein has a 52 week low of $73.35 and a 52 week high of $107.75. The stock has a 50-day moving average of $103.9 and a 200-day moving average of $96.51. The company has a market cap of $9.685 billion and a price-to-earnings ratio of 24.49.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.23. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same quarter last year, the company posted $1.11 earnings per share. Henry Schein’s revenue was up 8.6% compared to the same quarter last year. On average, analysts predict that Henry Schein will post $4.89 earnings per share for the current fiscal year.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.